Cyberoo (CYB) H2 2025 & Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 & Q1 2026 earnings summary
19 Oct, 2026Executive summary
The 15-month fiscal year ended March 31, 2026, recorded €27.71m in sales and services revenue and €31.23m in production value; comparisons with the prior 12-month period are not fully comparable.
Strategy focused on the ORBIS ecosystem, proprietary products, vCISO consulting, distribution and international reach; more than 200 vCISO contracts were activated.
Financial highlights
Production value was €31.23m, up 24.85%; sales and services revenue was €27.71m, up 21.37% versus €22.84m for the prior 12 months.
EBITDA was €8.56m versus €9.72m, with a 27.4% margin; net profit was €2.57m versus €4.38m. The periods were not fully comparable.
EBIT was €4.32m versus €6.47m; net financial expenses were €0.50m versus €0.23m.
Total liquidity was €17.73m versus €6.45m; net financial position was a €0.84m net cash position versus €0.02m.
Outlook and guidance
Continued R&D, including AI initiatives and a mobile-first evolution of Keatrix, plus stronger national and international distribution, support growth plans.
Keatrix development, distribution and expanded sales channels remain priorities; new platform announcements were planned from July to support NIS2 compliance and cyber-risk governance.
Near-term demand is difficult to predict amid macroeconomic and market uncertainty, while cybersecurity’s growing importance remains a structural growth driver.
Latest events from Cyberoo
- Cyber Security revenue grew 51.7% as H1 EBITDA rose 53.9%.CYB
H1 2023 - Cybersecurity-led growth lifted revenues 28.7%, with EBITDA margin reaching 42.15%.CYB
H2 2023 - 2023 revenue rose 25.4% as EBITDA margin reached 42.2%.CYB
Investor presentation - FY2023 growth and expanding MDR reach contrast with lower H1 2024 profit.CYB
Investor presentation - Revenue rose 16.24% as profit fell and international expansion advanced.CYB
H1 2024 - H1 revenue grew 14.56% as MDR and international expansion underpin the strategy.CYB
Investor presentation - Revenue rose 14.1% as AI investment and European expansion continued; net financial position improved.CYB
H2 2024 - Stable revenue and higher production value accompanied lower earnings; MDR and Keatrix offer growth potential.CYB
H1 2025 - Keatrix investment and vCISO growth weighed on margins as revenue expanded.CYB
H1 2026